AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15250777 — intervention group
Group type: EXPERIMENTAL
Intervention: Sum-difference Theory of remembering and knowing (STREAK)
Number of subjects: 373
Study 15250777 — intervention group
Group type: COMPARATOR
Intervention: One-dimensional model
Number of subjects: 373
Study 11852167 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned cesarean section
Number of subjects: 2088
Study 11852167 — intervention group
Group type: COMPARATOR
Intervention: Planned vaginal birth
Number of subjects: 2088
Study 9226356 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat yogurt condition
Number of subjects: 40
Study 9226356 — intervention group
Group type: COMPARATOR
Intervention: Low-fat yogurt condition
Number of subjects: 40
Study 9226356 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate content (varied in yogurt)
Number of subjects: 40
Study 8497553 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity exercise (70% VO2max)
Number of subjects: 72
Study 8497553 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise (50% VO2max)
Number of subjects: 72
Study 8497553 — intervention group
Group type: COMPARATOR
Intervention: Light exercise control
Number of subjects: 72
Study 3802930 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone aerosol (BA)
Number of subjects: 12
Study 3802930 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Plc)
Number of subjects: 12
Study 3802930 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchodilator pretreatment
Number of subjects: 12
Study 3802930 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased dose oral steroid therapy
Number of subjects: 12
Study 30790724 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency neurotomy (RN)
Number of subjects: 40
Study 30790724 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic neurotomy (EN)
Number of subjects: 40
Study 28531269 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% caloric restriction (n = 145; 11.7% caloric restriction achieved on average)
Number of subjects: 220
Study 28531269 — intervention group
Group type: COMPARATOR
Intervention: Maintain current diet (n = 75)
Number of subjects: 220
Study 24233256 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber-blend fortified enteral formula (FB, 15 g/L)
Number of subjects: 20
Study 24233256 — intervention group
Group type: COMPARATOR
Intervention: Fiber-free formula (FF)
Number of subjects: 20
Study 24233256 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet
Number of subjects: 20
Study 24521695 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimotuzumab (200 mg doses, first 6 doses weekly, then every 21 days for up to 1 year)
Number of subjects: 35
Study 24521695 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimotuzumab in combination with radiotherapy
Number of subjects: 35
Study 24521695 — intervention group
Group type: COMPARATOR
Intervention: Matched population treated with irradiation alone
Number of subjects: 35
Study 22119456 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Training (ET)
Number of subjects: 36
Study 22119456 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Strength Training (ST)
Number of subjects: 36
Study 22119456 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination Training (CT)
Number of subjects: 36
Study 19949030 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (oMP) 1 g/day for 5 days
Number of subjects: 40
Study 19949030 — intervention group
Group type: COMPARATOR
Intervention: Intravenous methylprednisolone (IV MP) 1 g/day for 5 days
Number of subjects: 40
Study 17305736 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term topical steroid treatment (prednisolone acetate 1% eyedrops, stopped after 6 months)
Number of subjects: 305
Study 17305736 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term topical steroid treatment (prednisolone acetate 1% eyedrops, continued once a day until 12 months postoperatively)
Number of subjects: 305
Study 17305736 — intervention group
Group type: COMPARATOR
Intervention: Comparison between short-term and long-term groups
Number of subjects: 305
Study 15345740 — intervention group
Group type: EXPERIMENTAL
Intervention: Parkinsonism (defined as the presence of two or more categories of parkinsonian signs)
Number of subjects: 455
Study 15345740 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait impairment and bradykinesia
Number of subjects: 455
Study 15345740 — intervention group
Group type: EXPERIMENTAL
Intervention: Tremor and rigidity
Number of subjects: 455
Study 15345740 — intervention group
Group type: EXPERIMENTAL
Intervention: Coexistent moderate-to-severe cognitive impairment or stroke
Number of subjects: 455
Study 11797069 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.60 g/kg alcohol
Number of subjects: 18
Study 11797069 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.27 g/kg alcohol
Number of subjects: 18
Study 11797069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 9766764 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonazepam (0.5 mg h.s. adjusted to two tablets by day 10 if needed)
Number of subjects: 80
Study 9766764 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (20 mg/day for all patients initially and 40 mg/day if needed after 6 weeks)
Number of subjects: 80
Study 7880577 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient follow-up care
Number of subjects: 909
Study 7880577 — intervention group
Group type: COMPARATOR
Intervention: General practice follow-up care
Number of subjects: 909
Study 3068610 — intervention group
Group type: EXPERIMENTAL
Intervention: Broncho‐Vaxom (BV)
Number of subjects: 51
Study 3068610 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 1912206 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional method (TN) - negative approach warning of disease and death
Number of subjects: 3
Study 1912206 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive treatment (TP) - positive reinforcement focused on quality of life
Number of subjects: 3
Study 1912206 — intervention group
Group type: COMPARATOR
Intervention: Control group - without therapy
Number of subjects: 3
Study 895528 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan (10 g orally administered)
Number of subjects: 14
Study 895528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 31522843 — intervention group
Group type: COMPARATOR
Intervention: Standard shunt
Number of subjects: 1605
Study 31522843 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic-impregnated shunt (0.15% clindamycin and 0.054% rifampicin)
Number of subjects: 1605
Study 31522843 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver shunt
Number of subjects: 1605
Study 31522843 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic-impregnated shunt
Number of subjects: 1605
Study 27918333 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural Analgesia (EA)
Number of subjects: 60
Study 27918333 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Surgical Site Analgesia (CSSA)
Number of subjects: 60
Study 27918333 — intervention group
Group type: COMPARATOR
Intervention: Control (Patient-Controlled Analgesic Morphine)
Number of subjects: 60
Study 23579520 — intervention group
Group type: EXPERIMENTAL
Intervention: Transumbilical single-incision laparoscopic appendectomy (TSILA)
Number of subjects: 84
Study 23579520 — intervention group
Group type: COMPARATOR
Intervention: Classic 3-port laparoscopic appendectomy
Number of subjects: 84
Study 20653608 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR) exercise
Number of subjects: 15
Study 20653608 — intervention group
Group type: COMPARATOR
Intervention: Control exercise
Number of subjects: 15
Study 19808215 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly dosing (QW) of epoetin alfa
Number of subjects: 375
Study 19808215 — intervention group
Group type: EXPERIMENTAL
Intervention: Biweekly dosing (Q2W) of epoetin alfa
Number of subjects: 375
Study 19808215 — intervention group
Group type: COMPARATOR
Intervention: Three times per week dosing (TIW) of epoetin alfa
Number of subjects: 375
Study 16710858 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative administration of 500 mg of methylprednisolone
Number of subjects: 76
Study 16710858 — intervention group
Group type: COMPARATOR
Intervention: Control group (no steroids)
Number of subjects: 76
Study 15273831 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (400 mg)
Number of subjects: 15
Study 15273831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 11316330 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin secretion estimated by overnight urinary excretion of 6-sulphatoxymelatonin
Number of subjects: 159
Study 11316330 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 159
Study 11316330 — intervention group
Group type: EXPERIMENTAL
Intervention: Birthweight and ponderal index at birth
Number of subjects: 159
Study 11316330 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of gestation
Number of subjects: 159
Study 11316330 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult body mass index
Number of subjects: 159
Study 9265122 — intervention group
Group type: EXPERIMENTAL
Intervention: Milligan‐Morgan operation
Number of subjects: 135
Study 9265122 — intervention group
Group type: EXPERIMENTAL
Intervention: Diathermy hemorrhoidectomy
Number of subjects: 135
Study 9265122 — intervention group
Group type: COMPARATOR
Intervention: Closed hemorrhoidectomy (Ferguson and Khubchandani)
Number of subjects: 135
Study 9265122 — intervention group
Group type: EXPERIMENTAL
Intervention: Milligan‐Morgan and diathermy hemorrhoidectomy without peduncle ligature
Number of subjects: 135
Study 8205740 — intervention group
Group type: EXPERIMENTAL
Intervention: Penmix 10:90
Number of subjects: 17
Study 8205740 — intervention group
Group type: EXPERIMENTAL
Intervention: Penmix 20:80
Number of subjects: 17
Study 8205740 — intervention group
Group type: EXPERIMENTAL
Intervention: Penmix 30:70
Number of subjects: 17
Study 8205740 — intervention group
Group type: EXPERIMENTAL
Intervention: Penmix 40:60
Number of subjects: 17
Study 8205740 — intervention group
Group type: EXPERIMENTAL
Intervention: Penmix 50:50
Number of subjects: 17
Study 2433932 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine 120 mg, started within 24 hours after onset of stroke, combined with standard treatment (hemodilution using low molecular dextran)
Number of subjects: 0
Study 2433932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31211660 — intervention group
Group type: EXPERIMENTAL
Intervention: Second Step Child Protection Unit (CPU)
Number of subjects: 161
Study 28902817 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyostimulation (EMS) of the crural muscles with the 'Veinoplus VI' unit (three 30-minute sessions a day)
Number of subjects: 60
Study 28902817 — intervention group
Group type: COMPARATOR
Intervention: Control Group (comprehensive therapy including wearing a compression knee sock, phlebotrophic drugs, and dosed walking)
Number of subjects: 60
Study 25780462 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxapram (1 mg/kg)
Number of subjects: 60
Study 25780462 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 60
Study 22841755 — intervention group
Group type: EXPERIMENTAL
Intervention: Power-related film clips
Number of subjects: 17
Study 22841755 — intervention group
Group type: EXPERIMENTAL
Intervention: Love stories
Number of subjects: 17
Study 22841755 — intervention group
Group type: COMPARATOR
Intervention: Control movie clips
Number of subjects: 17
Study 21690512 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D educational computer model
Number of subjects: 100
Study 21690512 — intervention group
Group type: COMPARATOR
Intervention: Standard written instruction (SWI)
Number of subjects: 100
Study 18457589 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmural collaborative care model including Problem Solving Treatment (PST), workplace intervention, antidepressant medication, and manual guided self-help.
Number of subjects: 126
Study 18457589 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU).
Number of subjects: 126
Study 17142415 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom brace
Number of subjects: 10
Study 17142415 — intervention group
Group type: COMPARATOR
Intervention: Off-the-shelf brace
Number of subjects: 10
Study 12141721 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (TAA) 220 microg, two sprays/nostril once daily AM
Number of subjects: 352
Study 12141721 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 200 microg, two sprays/nostril once daily AM
Number of subjects: 352
Study 12141721 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 352
Study 10438709 — intervention group
Group type: EXPERIMENTAL
Intervention: SCF (20 micrograms/kg/d) combined with filgrastim (5 micrograms/kg/d)
Number of subjects: 102
Study 10438709 — intervention group
Group type: COMPARATOR
Intervention: Filgrastim alone (5 micrograms/kg/d)
Number of subjects: 102
Study 10438709 — intervention group
Group type: EXPERIMENTAL
Intervention: SCF plus filgrastim
Number of subjects: 102
Study 10438709 — intervention group
Group type: EXPERIMENTAL
Intervention: SCF (20 micrograms/kg/d)
Number of subjects: 102
Study 8867714 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg adrenaline
Number of subjects: 194
Study 8867714 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg adrenaline
Number of subjects: 194
Study 8867714 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study 2277735 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest physical therapy (PT)
Number of subjects: 38
Study 2277735 — intervention group
Group type: COMPARATOR
Intervention: Placebo visits
Number of subjects: 38
Study 375171 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone phosphate
Number of subjects: 127
Study 375171 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study 31739087 — intervention group
Group type: EXPERIMENTAL
Intervention: Early goal-directed therapy (EGDT)
Number of subjects: 1591
Study 31739087 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1591
Study 29236943 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction TPF (Docetaxel 75 mg/m2 day 1; cisplatin 75 mg/m2 day 1; 5FU 750 mg/m2/day days 1-5) plus concomitant cisplatin-RT (40 mg/m2 weekly)
Number of subjects: 83
Study 29236943 — intervention group
Group type: COMPARATOR
Intervention: Concomitant cisplatin-RT alone
Number of subjects: 83
Study 29236943 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction TPF plus concomitant cisplatin-RT
Number of subjects: 83
Study 26200815 — intervention group
Group type: EXPERIMENTAL
Intervention: Local injection of methylcobalamin and lidocaine combination for 14 days (A1, B1)
Number of subjects: 98
Study 26200815 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular methylcobalamin in addition to local lidocaine injection (A0, B0)
Number of subjects: 98
Study 24919410 — intervention group
Group type: EXPERIMENTAL
Intervention: Travoprost/timolol BAK-free (TTFC)
Number of subjects: 42
Study 24919410 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost/timolol fixed combination (LTFC)
Number of subjects: 42
Study 22532465 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilpivirine (25 mg once daily)
Number of subjects: 1335
Study 22532465 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz (600 mg once daily)
Number of subjects: 1335
Study 22532465 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilpivirine
Number of subjects: 1335
Study 22532465 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 1335
Study 20216105 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient enriched formula (A, n=56)
Number of subjects: 164
Study 20216105 — intervention group
Group type: COMPARATOR
Intervention: Term infant formula (B, n=57)
Number of subjects: 164
Study 20216105 — intervention group
Group type: COMPARATOR
Intervention: Nutrient enriched plus term formula (C, n=26)
Number of subjects: 164
Study 20216105 — intervention group
Group type: COMPARATOR
Intervention: Breast-fed preterm infants (D, n=25)
Number of subjects: 164
Study 17559729 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 120 mg/day
Number of subjects: 188
Study 17559729 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram 20 mg/day
Number of subjects: 188
Study 17559729 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study 15613407 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant methionyl human leptin (r‐metHuLeptin) administration
Number of subjects: 3
Study 15613407 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant methionyl human leptin (r‐metHuLeptin) administration for 4 or 16 weeks
Number of subjects: 3
Study 12401414 — intervention group
Group type: EXPERIMENTAL
Intervention: telephone follow-up
Number of subjects: 320
Study 12401414 — intervention group
Group type: EXPERIMENTAL
Intervention: community resources utilization component
Number of subjects: 320
Study 12401414 — intervention group
Group type: EXPERIMENTAL
Intervention: basic touchscreen computer-assisted dietary goal-setting intervention
Number of subjects: 320
Study 12401414 — intervention group
Group type: COMPARATOR
Intervention: control condition without goal setting
Number of subjects: 320
Study 10101627 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethaphan (TMP)
Number of subjects: 28
Study 10101627 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (TNG)
Number of subjects: 28
Study 10101627 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1)
Number of subjects: 28
Study 7592204 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold dry air inhalation and exhalation
Number of subjects: 10
Study 7592204 — intervention group
Group type: COMPARATOR
Intervention: Warm moist air inhalation and exhalation
Number of subjects: 10
Study 2185723 — intervention group
Group type: EXPERIMENTAL
Intervention: Cysteamine eye drops
Number of subjects: 29
Study 45059 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 m² hollow-fibre dialyser
Number of subjects: 0
Study 45059 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.4 m² coil dialyser
Number of subjects: 0
Study 45059 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetate dialysate with high-efficiency dialyser
Number of subjects: 0
Study 45059 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicarbonate as the source of base
Number of subjects: 0
Study 31622954 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐Assessment of Sleep Survey (SASS)
Number of subjects: 131
Study 31622954 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐Assessment of Sleep Survey - Split (SASS‐Y)
Number of subjects: 131
Study 31622954 — intervention group
Group type: COMPARATOR
Intervention: Pittsburgh Sleep Quality Index (PSQI)
Number of subjects: 131
Study 28569619 — intervention group
Group type: EXPERIMENTAL
Intervention: Point massage of liver and stomach channel
Number of subjects: 320
Study 28569619 — intervention group
Group type: EXPERIMENTAL
Intervention: Pith and trotter soup
Number of subjects: 320
Study 28569619 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage + soup
Number of subjects: 320
Study 28569619 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine nursing)
Number of subjects: 320
Study 27608978 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated neonatal survival kit and early stimulation package delivered by community health workers
Number of subjects: 0
Study 27608978 — intervention group
Group type: COMPARATOR
Intervention: Current standard of care
Number of subjects: 0
Study 25134497 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic Self Transcending Meditation (ASTM) plus Treatment as Usual (TAU)
Number of subjects: 0
Study 25134497 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) alone
Number of subjects: 0
Study 22390410 — intervention group
Group type: EXPERIMENTAL
Intervention: Major Depressive Syndrome (MDS)
Number of subjects: 251
Study 22390410 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety Syndrome (AS)
Number of subjects: 251
Study 22390410 — intervention group
Group type: EXPERIMENTAL
Intervention: Situationally based self‐efficacy
Number of subjects: 251
Study 22390410 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectancies of controlling negative affect by means other than smoking
Number of subjects: 251
Study 22390410 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimensions of primary and secondary tobacco dependence
Number of subjects: 251
Study 22390410 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐efficacy in negative/affective situations
Number of subjects: 251
Study 19670975 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 24
Study 19670975 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 24
Study 19670975 — intervention group
Group type: EXPERIMENTAL
Intervention: Both surgical methods
Number of subjects: 24
Study 17443369 — intervention group
Group type: EXPERIMENTAL
Intervention: Group visits
Number of subjects: 186
Study 17443369 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 186
Study 15996356 — intervention group
Group type: EXPERIMENTAL
Intervention: One-stage surgery (group A)
Number of subjects: 108
Study 15996356 — intervention group
Group type: COMPARATOR
Intervention: Two-stage surgery (group B) - Control group
Number of subjects: 108
Study 15996356 — intervention group
Group type: EXPERIMENTAL
Intervention: One-piece implants (group C)
Number of subjects: 108
Study 15996356 — intervention group
Group type: EXPERIMENTAL
Intervention: Early loading (group D)
Number of subjects: 108
Study 11953624 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy focused on the calcified area (4000 impulses, 0.78 mJ/mm2, 2 sessions)
Number of subjects: 50
Study 11953624 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal shock wave therapy focused on the origin of the supraspinatus tendon (4000 impulses, 0.78 mJ/mm2, 2 sessions)
Number of subjects: 50
Study 9861127 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 20 micrograms kg‐1
Number of subjects: 160
Study 1993631 — intervention group
Group type: EXPERIMENTAL
Intervention: Misonidazole 1 g/m2 with 3.0 Gy x 10 fractions
Number of subjects: 859